Ozempic's Expanding Universe: Asthma Relief, Bipolar Benefits, and the Mental Health Paradox

Semaglutide — the blockbuster drug behind Ozempic and Wegovy — appears to cut asthma attacks by 38% and bipolar disorder hospitalizations by 21% in two large studies presented this week. But a separate Korean analysis flags 2.7 times higher odds of suicidal ideation among weight-loss drug users who regained weight.

Plain English

These weight-loss drugs keep surprising researchers. A UK team tracked over 20,000 people with asthma and found those on semaglutide...